by the SEC Office, as the Company’s independent financial advisor to provide its opinion on the disposal of assets, which is a connected transaction of the Company. Please be informed accordingly
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
Company Limited No. 9/2560 held on December 20, 2017 had considered and approved the Company to perform juristic act to sell an integrated piece of land consist of totally 5 title deeds located in Tumbol
which had been audited by the independent auditor as follows: Consolidated financial statements The Group Company reported profit attributable to owners of the Company for the year 2018 in the amount of
quarter ended 31 March 2019 which had been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company for Q1/2019 in
the first quarter ended 31 March 2018 which has been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company for
the third quarter ended 30 September 2018 which had been reviewed by the independent auditor as follows: Consolidated financial statements The Group reported profit attributable to owners of the Company
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.172/2018 30 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
December 2008, the Office hereby issues the following regulations: Clause 1 A company wishing to offer for sale of newly issued share warrants and underlying shares to the public shall file with the Office